Texas 2021 - 87th Regular

Texas House Bill HB18 Compare Versions

OldNewDifferences
1-H.B. No. 18
1+By: Oliverson, et al. (Senate Sponsor - Kolkhorst) H.B. No. 18
2+ (In the Senate - Received from the House April 19, 2021;
3+ May 10, 2021, read first time and referred to Committee on Health &
4+ Human Services; May 20, 2021, reported adversely, with favorable
5+ Committee Substitute by the following vote: Yeas 8, Nays 0;
6+ May 20, 2021, sent to printer.)
7+Click here to see the committee vote
8+ COMMITTEE SUBSTITUTE FOR H.B. No. 18 By: Hall
29
310
11+ A BILL TO BE ENTITLED
412 AN ACT
513 relating to establishment of the prescription drug savings program
614 for certain uninsured individuals.
715 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
816 SECTION 1. SHORT TITLE. This Act shall be known as "Texas
917 Cares."
1018 SECTION 2. PRESCRIPTION DRUG SAVINGS PROGRAM. Subtitle C,
1119 Title 2, Health and Safety Code, is amended by adding Chapter 65 to
1220 read as follows:
1321 CHAPTER 65. PRESCRIPTION DRUG SAVINGS PROGRAM FOR CERTAIN
1422 UNINSURED INDIVIDUALS
1523 SUBCHAPTER A. GENERAL PROVISIONS
1624 Sec. 65.001. DEFINITIONS. In this chapter:
1725 (1) "Enrollee" means an individual enrolled in the
1826 program.
1927 (2) "Fund" means the trust fund established under
2028 Section 65.101.
2129 (3) "Pharmacy benefit manager" has the meaning
2230 assigned by Section 4151.151, Insurance Code.
2331 (4) "Prescription drug" has the meaning assigned by
2432 Section 551.003, Occupations Code.
2533 (5) "Program" means the prescription drug savings
2634 program established under this chapter.
2735 (6) "Uninsured individual" means an individual
2836 without health benefit plan coverage for a prescription drug
2937 benefit.
3038 Sec. 65.002. CONSTRUCTION OF CHAPTER; PURPOSE. (a) This
3139 chapter does not establish an entitlement to assistance in
3240 obtaining benefits for uninsured individuals.
3341 (b) The purpose of this chapter is to establish a program to
3442 provide uninsured individuals access to prescription drug benefits
3543 using money from the fund to pay an amount equal to the value of a
3644 prescription drug rebate at the point of sale and returning that
3745 rebate amount to the fund to ensure the amounts credited to the fund
3846 equal the amounts paid from the fund.
3947 (c) This chapter does not expand the Medicaid program.
4048 Sec. 65.003. RULES. The executive commissioner shall adopt
4149 rules as necessary to implement this chapter.
4250 SUBCHAPTER B. ESTABLISHMENT AND ADMINISTRATION OF PRESCRIPTION
4351 DRUG SAVINGS PROGRAM
4452 Sec. 65.051. ESTABLISHMENT OF PROGRAM. (a) The commission
4553 shall develop and design a prescription drug savings program that
4654 partners with a pharmacy benefit manager to offer prescription
4755 drugs at a discounted rate to uninsured individuals.
4856 (b) In developing and implementing the program, the
4957 commission shall ensure the program benefits do not include
5058 prescription drugs used for the elective termination of a
5159 pregnancy.
5260 (c) The executive commissioner shall ensure the program is
5361 designed to provide the greatest possible value to uninsured
5462 individuals served by the program, while considering the adequacy
5563 of the prescription drug formulary, net costs of the drugs to
5664 enrollees, cost to the state, and other important factors
5765 determined by the commission.
5866 Sec. 65.052. GENERAL POWERS AND DUTIES OF COMMISSION
5967 RELATED TO PROGRAM. (a) The commission shall oversee the
6068 implementation of the program and coordinate the activities of each
6169 state agency involved in that implementation.
6270 (b) The commission shall design the program to be cost
6371 neutral by collecting prescription drug rebates after using money
6472 in the fund in amounts equal to the rebate amounts to purchase
6573 prescription drugs.
6674 (c) The commission shall develop procedures for accepting
6775 applications for program enrollment, including a process to:
6876 (1) determine eligibility, screening, and enrollment
6977 procedures that allow applicants to self attest to the extent
7078 authorized by federal law; and
7179 (2) resolve disputes related to eligibility
7280 determinations.
7381 (d) The commission shall publish on an Internet website all
7482 average consumer costs for each prescription drug available through
7583 the program.
7684 (e) The commission and the contracted pharmacy benefit
7785 manager shall integrate manufacturer and other third-party patient
7886 assistance programs into the program to the extent feasible. A
7987 manufacturer or other third party may decline to link the
8088 manufacturer's or third party's patient assistance program to the
8189 program. The commission shall give preference to integrating
8290 patient assistance programs by listing information on those patient
8391 assistance programs in a central location on the Internet website
8492 described by Subsection (d) that directs patients to those patient
8593 assistance programs as appropriate.
8694 (f) The commission shall ensure the program has access to an
8795 adequate pharmacy network and give preference to conducting the
8896 program using a state pharmaceutical assistance program.
8997 (g) The commission is not required to enter into stand-alone
9098 contracts under this chapter. The commission may add the program,
9199 wholly or partly, to existing contracts to increase efficiency.
92100 Sec. 65.053. PHARMACY BENEFIT MANAGER CONTRACT,
93101 MONITORING, AND REPORTING REQUIREMENTS. (a) The commission shall
94102 contract with a pharmacy benefit manager to provide discounted
95103 prescription drugs to enrollees under the program.
96104 (b) The commission shall monitor through reporting or other
97105 methods the contracted pharmacy benefit manager to ensure
98106 performance under the contract and quality delivery of services.
99107 (c) The contracted pharmacy benefit manager shall report to
100108 the commission on the commission's request information related to
101109 the program, including information on rebate amounts, prescription
102110 drug rates contracted with pharmacies, administrative costs, and
103111 out-of-pocket costs paid by enrollees at the point of sale of the
104112 prescription drugs.
105113 Sec. 65.054. CONTRACT FUNCTIONS. (a) The commission may
106114 contract with a third-party administrator or other entity to
107115 perform any or all program functions for the commission under this
108116 chapter.
109117 (b) A third-party administrator or other entity may perform
110118 tasks under a contract entered into under Subsection (a) that would
111119 otherwise be performed by the commission.
112120 Sec. 65.055. COMMUNITY OUTREACH CAMPAIGN. The commission
113121 shall conduct or contract to conduct a community outreach and
114122 education campaign in the form and manner determined by the
115123 commission to provide information on the program's availability to
116124 eligible individuals.
117125 SUBCHAPTER C. TRUST FUND; PROGRAM SUSPENSION
118126 Sec. 65.101. ESTABLISHMENT OF FUND. (a) A trust fund is
119127 established outside the state treasury for the purposes of this
120128 chapter.
121129 (b) The fund consists of:
122130 (1) gifts, grants, and donations received by this
123131 state for the purposes of the fund;
124132 (2) legislative appropriations of money for the
125133 purposes of this chapter;
126134 (3) federal money available to this state that by law
127135 may be used for the purposes of this chapter; and
128136 (4) interest, dividends, and other income of the fund.
129137 (c) The commission shall administer the fund as trustee for
130138 the benefit of the program established by this chapter.
131139 (d) Money in the fund may be used only to administer the
132140 program and provide program services.
133141 (e) The commission shall ensure money spent from the fund to
134142 assist enrollees in purchasing prescription drugs is cost neutral
135143 after collecting the prescription drug rebates under the program.
136144 (f) The commission may solicit and accept gifts, grants, and
137145 donations for the fund.
138146 Sec. 65.102. SUFFICIENT FUNDING REQUIRED. Notwithstanding
139147 any other provision of this chapter, the commission is not required
140148 to implement the program unless money is provided and by law made
141149 available for deposit to the credit of the fund.
142150 Sec. 65.103. SUSPENSION OF PROGRAM. On the fourth
143151 anniversary of the date the program is established, the commission
144152 shall suspend the program and seek legislative approval to continue
145153 the program unless the ongoing costs of administering the program
146154 are fully funded through enrollee cost sharing.
147155 SUBCHAPTER D. PROGRAM ELIGIBILITY AND ENROLLEE REQUIREMENTS
148156 Sec. 65.151. ELIGIBILITY CRITERIA. (a) Except as provided
149157 by Subsection (b), an individual is eligible for benefits under the
150158 program if the individual is:
151159 (1) a resident of this state;
152160 (2) a citizen or lawful permanent resident of the
153161 United States; and
154162 (3) uninsured, as determined by the commission.
155163 (b) If the commission determines necessary, the commission
156164 may consider an applicant's financial vulnerability as an
157165 additional factor for determining program eligibility.
158166 Sec. 65.152. COST SHARING. (a) To the extent necessary,
159167 the commission shall require enrollees to share the cost of the
160168 program, including requiring enrollees to pay a copayment at the
161169 point of sale of a prescription drug.
162170 (b) The commission must:
163171 (1) allow an enrollee to pay all or part of the
164172 enrollee's share from any source the enrollee selects; and
165173 (2) accept another assistance program if that
166174 assistance program wholly or partly covers the enrollee share of
167175 the prescription drug cost.
168176 (c) The commission shall require an enrollee to pay a
169177 copayment to compensate the pharmacy, pharmacy benefit manager, and
170178 commission for the costs of administering the program in accordance
171179 with Subsection (d) and under the methodology determined by the
172180 commission.
173181 (d) Enrollees shall pay the costs of ongoing administration
174182 of the program through an additional charge at the point of sale of
175183 an eligible prescription drug only if the total number of enrollees
176184 in the program allows for the additional charge to be an amount not
177185 to exceed the lesser of:
178186 (1) an amount similar to the amount charged for a
179187 prescription drug in other state pharmaceutical assistance
180188 programs administered by the commission; or
181189 (2) 10 percent of the total amount charged at the point
182190 of sale for the prescription drug.
183191 SUBCHAPTER E. OPERATION OF PROGRAM
184192 Sec. 65.201. PROGRAM BENEFITS. The commission must approve
185193 program benefits offered under this chapter. The commission shall
186194 ensure the benefits comply with all applicable federal and state
187195 laws, rules, and regulations.
188196 Sec. 65.202. REPORTING. (a) A third-party administrator,
189197 pharmacy benefit manager, or any other entity the commission
190198 contracts with under Section 65.054 shall report to the commission
191199 in the form and manner prescribed by the commission on the benefits
192200 and services provided under the program.
193201 (b) The commission shall establish a procedure to monitor
194202 the provision of benefits and services under this chapter.
195203 Sec. 65.203. FRAUD PREVENTION. The executive commissioner
196204 by rule shall develop and implement fraud prevention and detection
197205 for pharmacy benefit managers, contracted third parties, and other
198206 entities involved in the program.
199207 Sec. 65.204. ANNUAL PROGRAM REPORTS. Not later than
200208 December 1 of each year, the commission shall provide a written
201209 report to the governor, lieutenant governor, speaker of the house
202210 of representatives, and standing committees of the legislature with
203211 primary jurisdiction over the program. The report must include:
204212 (1) a line-item list of all program administrative
205213 costs incurred by the commission;
206214 (2) the amount of the pharmacy benefit manager and
207215 third-party administrator fees;
208216 (3) the aggregate amounts of rebates anticipated and
209217 received for the program; and
210218 (4) other program expenditures as the commission
211219 determines appropriate.
212220 SECTION 3. INSULIN STUDY. (a) In this section,
213221 "commission" means the Health and Human Services Commission.
214222 (b) The commission shall conduct a study on the development
215223 and implementation of the prescription drug savings program
216224 established by Chapter 65, Health and Safety Code, as added by this
217225 Act, in providing post-rebate insulin to enrollees. The commission
218226 shall determine the effectiveness of the program in providing
219227 insulin-related services to uninsured individuals in this state and
220228 any legislative recommendations for improvements to the program.
221229 (c) Not later than February 14, 2023, the commission shall
222230 provide a written report of the results of the study conducted under
223231 Subsection (b) of this section to the governor, lieutenant
224232 governor, speaker of the house of representatives, and members of
225233 the standing committees of the legislature with primary
226234 jurisdiction over the commission. The study must include at least
227235 six months of information on use by and cost to enrollees for
228236 prescription insulin.
229237 SECTION 4. GENERAL STUDY. (a) In this section,
230238 "commission" means the Health and Human Services Commission.
231239 (b) The commission shall conduct a study on the development
232240 and implementation of the prescription drug savings program
233241 established by Chapter 65, Health and Safety Code, as added by this
234242 Act, in providing to enrollees all of the post-rebate formulary of
235243 prescription drugs. The commission shall determine the
236244 effectiveness of the program in providing prescription
237245 drug-related services to uninsured individuals in this state and
238246 any legislative recommendations for improvements to the program.
239247 (c) Not later than February 14, 2025, the commission shall
240248 provide a written report on the results of the study conducted under
241249 Subsection (b) of this section to the governor, lieutenant
242250 governor, speaker of the house of representatives, and standing
243251 committees of the legislature with primary jurisdiction over the
244252 commission. The study must include at least one year of information
245253 on use by and cost to enrollees for all of the formulary of
246254 prescription drugs.
247255 SECTION 5. TRANSITION. (a) The Health and Human Services
248256 Commission is not required to submit the initial report under
249257 Section 65.204, Health and Safety Code, as added by this Act, until
250258 December 1, 2022.
251259 (b) The Health and Human Services Commission is required to
252260 implement a provision of this Act only if the legislature
253261 appropriates money specifically for that purpose. If the
254262 legislature does not appropriate money specifically for that
255263 purpose, the Health and Human Services Commission may, but is not
256264 required to, implement a provision of this Act using other
257265 appropriations available for that purpose.
258266 SECTION 6. RULES. As soon as practicable after the
259267 effective date of this Act, the executive commissioner of the
260268 Health and Human Services Commission and any other state agency
261269 designated by the executive commissioner shall adopt rules
262270 necessary to implement Chapter 65, Health and Safety Code, as added
263271 by this Act.
264272 SECTION 7. EFFECTIVE DATE. This Act takes effect September
265273 1, 2021.
266- ______________________________ ______________________________
267- President of the Senate Speaker of the House
268- I certify that H.B. No. 18 was passed by the House on April
269- 15, 2021, by the following vote: Yeas 144, Nays 1, 1 present, not
270- voting; and that the House concurred in Senate amendments to H.B.
271- No. 18 on May 28, 2021, by the following vote: Yeas 146, Nays 0, 1
272- present, not voting.
273- ______________________________
274- Chief Clerk of the House
275- I certify that H.B. No. 18 was passed by the Senate, with
276- amendments, on May 22, 2021, by the following vote: Yeas 28, Nays
277- 2.
278- ______________________________
279- Secretary of the Senate
280- APPROVED: __________________
281- Date
282- __________________
283- Governor
274+ * * * * *